Evidence map›Paper›PMID 25951887›Full record

ArticleHistopathology2016

Resolving quandaries: basaloid adenoid cystic carcinoma or breast cylindroma? The role of massively parallel sequencing.

Nicola Fusco, Pierre-Emmanuel Colombo, Luciano G Martelotto, Maria R De Filippo, Salvatore Piscuoglio, Charlotte K Y Ng, Raymond S Lim, William Jacot, Anne Vincent-Salomon, Jorge S Reis-Filho and 1 more

Open access · greenAbstract readCase Reports
In one paragraph

Article in Histopathology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2016
    Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Nicola FuscoDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Pierre-Emmanuel ColomboDepartment of Surgical Oncology, Montpellier Cancer Institute (ICM), Montpellier, France.
Luciano G MartelottoDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-9625-1183
Maria R De FilippoDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Salvatore PiscuoglioDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Charlotte K Y NgDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Raymond S LimDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
William JacotDepartment of Surgical Oncology, Montpellier Cancer Institute (ICM), Montpellier, France.
Anne Vincent-SalomonDepartment of Tumor Biology, Institut Curie, Paris, France.
Jorge S Reis-FilhoDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Britta WeigeltDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Memorial Sloan Kettering Cancer Center · USInstitut de Recherche en Cancérologie de Montpellier · FRInstitut Curie · FR

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748NCI NIH HHS P30CA008748
6 · The paper itself

Abstract

aimsThe aims of this study were to perform a whole-exome sequencing analysis of a breast cylindroma and to investigate the role of molecular analyses in the differentiation between breast cylindroma, a benign tumour that displays MYB expression, and CYLD gene mutations, and its main differential diagnosis, the breast solid-basaloid adenoid cystic carcinoma, a malignant tumour that is characterized by the presence of the MYB-NFIB fusion gene and MYB overexpression. METHODS AND

resultsA 66-year-old female underwent quadrantectomy after an irregular dense shadow was discovered in the right breast at the screening mammogram. Histologically, the tumour displayed features suggestive of a solid-basaloid variant of adenoid cystic carcinoma with a differential diagnosis of cylindroma. Fluorescence in situ hybridization, reverse transcription-polymerase chain reaction, immunohistochemistry and whole-exome sequencing revealed absence of the MYB-NFIB fusion gene, low levels of MYB protein expression and a clonal somatic CYLD splice site mutation associated with loss of heterozygosity of the wild-type allele.

conclusionsThe results of the histological, immunohistochemical and molecular analyses were consistent with a diagnosis of breast cylindroma, providing a proof-of-principle that the integration of histopathological and molecular approaches can help to differentiate between a low-malignant potential and a benign breast tumour of triple-negative phenotype.

Indexed as

AgedBiomarkers, TumorBreastBreast NeoplasmsCarcinoma, Adenoid CysticExomeFemaleHigh-Throughput Nucleotide SequencingHumansImmunohistochemistryIn Situ Hybridization, FluorescenceMastectomy, SegmentalPhenotypeSequence Analysis, DNABiomarkers, Tumoradenoid cystic carcinomabreast cancercylindromafluorescence in-situ hybridizationmassively parallel sequencing

Identifiers

PMID25951887
PMCPMC4637261
OpenAlexW1574400789

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.